Company / Current Liabilities per Share
Apellis Pharmaceuticals, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$2.60
FY2025
5-year range
$1.55 / $2.60
FY2021-FY2025
Trend
+67.5%
vs FY2024
Sector context
#58 of 210
Health Care
What the data says
At $2.60, Apellis Pharmaceuticals, Inc.'s current liabilities per share ranks #153 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.31 in FY2018 to $2.60 in FY2025.
Based on SEC 10-K filings.
2.60 in FY2025 with a 5-year CAGR of +5.3%.
Increased from $2.24 to $2.60 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +14.8%
- 5-Year CAGR
- +5.3%
- 10-Year CAGR
- -
Sector benchmark
-89.1% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 67.5% year-over-year.
- Ranks #58 out of 210 companies in the Health Care sector.
- Lowest current liabilities per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -25.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.60 | +67.5% |
| FY2024 | $1.55 | -30.6% |
| FY2023 | $2.24 | +30.1% |
| FY2022 | $1.72 | -0.8% |
| FY2021 | $1.73 | -13.7% |
| FY2020 | $2.01 | +89.9% |
| FY2019 | $1.06 | +237.6% |
| FY2018 | $0.31 | -33.8% |
| FY2017 | $0.47 | +9.4% |
| FY2016 | $0.43 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026